Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Longitudinal transcriptional immune profiles and persistent wheezing in moderate-to-late preterm infants.
Rodriguez-Fernandez R, Xu Z, Moreno-Galdó A, Sardón O, Rubi T, Castillo-Corullón S, Torres A, Corcuera P, Callejón Callejón A, Perez G, Cortell I, Rovira-Amigo S, Pastor-Vivero MD, Mondejar-Lopez P, Perez-Frias J, Velasco V, Torres-Borrego J, Figuerola J, de la Serna Blázquez O, Garcia-Hernandez G, Tang L, Mejias A, Ramilo O; SAREPREM 3235 investigators. Rodriguez-Fernandez R, et al. Among authors: torres borrego j. Pediatr Allergy Immunol. 2024 Oct;35(10):e14261. doi: 10.1111/pai.14261. Pediatr Allergy Immunol. 2024. PMID: 39445663
Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life.
Pérez-Yarza EG, Moreno-Galdó A, Ramilo O, Rubí T, Escribano A, Torres A, Sardón O, Oliva C, Pérez G, Cortell I, Rovira-Amigo S, Pastor-Vivero MD, Pérez-Frías J, Velasco V, Torres-Borrego J, Figuerola J, Barrio MI, García-Hernández G, Mejías A; SAREPREM 3235 investigators. Pérez-Yarza EG, et al. Pediatr Allergy Immunol. 2015 Dec;26(8):797-804. doi: 10.1111/pai.12414. Epub 2015 Jul 1. Pediatr Allergy Immunol. 2015. PMID: 26031206
Dissecting Airborne Allergens.
Torres-Borrego J, Sánchez-Solís M. Torres-Borrego J, et al. J Clin Med. 2023 Sep 8;12(18):5856. doi: 10.3390/jcm12185856. J Clin Med. 2023. PMID: 37762797 Free PMC article. Review.
Incidence and Prevalence of Children's Diffuse Lung Disease in Spain.
Torrent-Vernetta A, Gaboli M, Castillo-Corullón S, Mondéjar-López P, Sanz Santiago V, Costa-Colomer J, Osona B, Torres-Borrego J, de la Serna-Blázquez O, Bellón Alonso S, Caro Aguilera P, Gimeno-Díaz de Atauri Á, Valenzuela Soria A, Ayats R, Martin de Vicente C, Velasco González V, Moure González JD, Canino Calderín EM, Pastor-Vivero MD, Villar Álvarez MÁ, Rovira-Amigo S, Iglesias Serrano I, Díez Izquierdo A, de Mir Messa I, Gartner S, Navarro A, Baz-Redón N, Carmona R, Camats-Tarruella N, Fernández-Cancio M, Rapp C, Dopazo J, Griese M, Moreno-Galdó A; ChILD-Spain Group. Torrent-Vernetta A, et al. Among authors: torres borrego j. Arch Bronconeumol. 2022 Jan;58(1):22-29. doi: 10.1016/j.arbres.2021.06.001. Epub 2021 Jun 17. Arch Bronconeumol. 2022. PMID: 35249699 Free article. English, Spanish.
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma.
Nieto García A, Garriga-Baraut T, Plaza Martín AM, Nieto Cid M, Torres Borrego J, Folqué Giménez MDM, Lozano Blasco J, Bosque García M, Moreno-Galarraga L, Tortajada-Girbés M, Rivas Juesas C, Penín Antón M, Caballero-Rabasco MA, Gaboli M, López Neyra A, Navarro Morón J, Freixa Benavente A, Valdesoiro Navarrete L, Ballester Asensio E, Sanz Santiago V, Romero García R, Gimeno Díaz de Atauri Á, Valenzuela Soria A, Sánchez Mateos M, Batlles Garrido J, Andrés Martín A, Campos Alonso E, Aragón Fernández C, Vázquez Rodríguez E, Martínez Pardo L, Del-Río Camacho G, Mazón Ramos Á. Nieto García A, et al. Among authors: torres borrego j. Pediatr Allergy Immunol. 2021 Jul;32(5):980-991. doi: 10.1111/pai.13484. Epub 2021 Mar 20. Pediatr Allergy Immunol. 2021. PMID: 33619748
Spanish multicentre study on morbidity and pathogenicity of tracheal bronchus in children.
Moreno M, Castillo-Corullón S, Pérez-Ruiz E, Luna MC, Antón-Pacheco JL, Mondejar-Lopez P, De-la-Serna O, Villa JR, Osona B, Torres-Borrego J, Santiago-Burruchaga M, Asensio O, Andres-Martin A, Delgado-Pecellin I, González Y, Palmero A, Escribano A. Moreno M, et al. Among authors: torres borrego j. Pediatr Pulmonol. 2019 Oct;54(10):1610-1616. doi: 10.1002/ppul.24435. Epub 2019 Jul 21. Pediatr Pulmonol. 2019. PMID: 31328420
Prevalence and factors linked to allergic rhinitis in 10 and 11-year-old children in Almería. Isaac Phase II, Spain.
Batlles-Garrido J, Torres-Borrego J, Rubí-Ruiz T, Bonillo-Perales A, González-Jiménez Y, Momblán-De Cabo J, Aguirre-Rodríguez J, Losillas-Maldonado A, Torres-Daza M. Batlles-Garrido J, et al. Allergol Immunopathol (Madr). 2010 May-Jun;38(3):135-41. doi: 10.1016/j.aller.2009.09.005. Epub 2010 May 11. Allergol Immunopathol (Madr). 2010. PMID: 20462685
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey.
Mondejar-Lopez P, Quintana-Gallego E, Giron-Moreno RM, Cortell-Aznar I, Ruiz de Valbuena-Maiz M, Diab-Caceres L, Prados-Sanchez C, Alvarez-Fernandez A, Garcia-Marcos PW, Peñalver-Mellado C, Pastor-Vivero MD, Olveira C, Lopez-Neyra A, Castillo-Corullon S, Palma-Milla S, Perez-Ruiz E, Sole-Jover A, Barrio MI, Sanchez-Solis M, Asensio de la Cruz Ó; CF-COVID19-Spain Registry Group. Mondejar-Lopez P, et al. Respir Med. 2020 Aug-Sep;170:106062. doi: 10.1016/j.rmed.2020.106062. Epub 2020 Jun 8. Respir Med. 2020. PMID: 32843180 Free PMC article.
Prevalence and factors linked to atopy in 10-and 11-year-old children in Almería, Spain.
Batllés-Garrido J, Torres-Borrego J, Rubí-Ruiz T, Bonillo-Perales A, González-Jiménez Y, Momblán De Cabo J, Aguirre-Rodríguez J, Losillas-Maldonado A, Torres-Daza M. Batllés-Garrido J, et al. Allergol Immunopathol (Madr). 2010 Jan-Feb;38(1):13-9. doi: 10.1016/j.aller.2009.07.006. Epub 2010 Jan 25. Allergol Immunopathol (Madr). 2010. PMID: 20092934
Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain.
Nieto-Cid M, Garriga-Baraut T, Plaza-Martín AM, Tortajada-Girbés M, Torres-Borrego J, Lozano-Blasco J, Moreno-Galarraga L, Del Mar Folqué-Giménez M, Bosque-García M, Gaboli M, López-Neyra A, Rivas-Juesas C, Caballero-Rabasco MA, Freixa-Benavente A, Valdesoiro-Navarrete L, de Mir-Messa I, Ballester-Asensio E, Penín-Antón M, Romero-García R, Navarro-Morón J, Valenzuela-Soria A, Sánchez-Mateos M, Batlles-Garrido J, Sanz-Santiago V, de Atauri ÁG, Andrés-Martín A, Campos-Alonso E, Gómez-Pastrana D, Vázquez-Rodríguez E, Martínez-Pardo L, Del Río-Camacho G, Mazón-Ramos Á, Nieto-García A. Nieto-Cid M, et al. Among authors: torres borrego j. Pediatr Allergy Immunol. 2023 Apr;34(4):e13942. doi: 10.1111/pai.13942. Pediatr Allergy Immunol. 2023. PMID: 37102393
38 results